Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue.
Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL. Miller LJ, et al. Among authors: lindquist rr. Anticancer Res. 1998 Jan-Feb;18(1A):77-81. Anticancer Res. 1998. PMID: 9568059
Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist.
Miller LJ, Kurtzman SH, Anderson K, Wang Y, Stankus M, Renna M, Lindquist R, Barrows G, Kreutzer DL. Miller LJ, et al. Cancer Invest. 2000;18(4):293-302. doi: 10.3109/07357900009012171. Cancer Invest. 2000. PMID: 10808364
Expression of vascular endothelial growth factor receptors in human prostate cancer.
Ferrer FA, Miller LJ, Lindquist R, Kowalczyk P, Laudone VP, Albertsen PC, Kreutzer DL. Ferrer FA, et al. Urology. 1999 Sep;54(3):567-72. doi: 10.1016/s0090-4295(99)00156-9. Urology. 1999. PMID: 10475375
Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells.
Eisma RJ, Spiro JD, von Biberstein SE, Lindquist R, Kreutzer DL. Eisma RJ, et al. Am J Surg. 1996 Dec;172(6):641-5. doi: 10.1016/s0002-9610(96)00305-4. Am J Surg. 1996. PMID: 8988667
Enhanced tumor cell expression of tumor necrosis factor receptors in head and neck squamous cell carcinoma.
von Biberstein SE, Spiro JD, Lindquist R, Kreutzer DL. von Biberstein SE, et al. Am J Surg. 1995 Nov;170(5):416-22. doi: 10.1016/s0002-9610(99)80320-1. Am J Surg. 1995. PMID: 7485723
Interleukin-1 receptor antagonist in head and neck squamous cell carcinoma.
von Biberstein SE, Spiro JD, Lindquist R, Kreutzer DL. von Biberstein SE, et al. Arch Otolaryngol Head Neck Surg. 1996 Jul;122(7):751-9. doi: 10.1001/archotol.1996.01890190047012. Arch Otolaryngol Head Neck Surg. 1996. PMID: 8663949
Cytokines in human breast cancer: IL-1alpha and IL-1beta expression.
Kurtzman SH, Anderson KH, Wang Y, Miller LJ, Renna M, Stankus M, Lindquist RR, Barrows G, Kreutzer DL. Kurtzman SH, et al. Among authors: lindquist rr. Oncol Rep. 1999 Jan-Feb;6(1):65-70. doi: 10.3892/or.6.1.65. Oncol Rep. 1999. PMID: 9864403
Cytotoxic T lymphocyte (CTL)-mediated cytolysis proceeds in the absence of Na+/H+ antiport activity: regulation of cytosolic pH by the Na+/H+ antiport in a cloned CTL.
Howcroft TK, Loew LM, Cragoe EJ Jr, Lindquist RR. Howcroft TK, et al. Among authors: lindquist rr. Cell Immunol. 1991 Jun;135(1):208-21. doi: 10.1016/0008-8749(91)90266-e. Cell Immunol. 1991. PMID: 1850326
Membranolytic and nucleolytic activities of cytolytic T lymphocyte clones.
Cosgrove JM, Howcroft TK, Tatum SM, Lindquist RR. Cosgrove JM, et al. Among authors: lindquist rr. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1562-7. doi: 10.1016/0006-291x(91)91751-w. Biochem Biophys Res Commun. 1991. PMID: 1930195
The effect of the synthetic lecithin analogue, dimethyl-DL-2, 3-distearolyoxypropyl-2'hydroxylethylammonium acetate, on cytolytic T lymphocyte (CTL) activity.
Lindquist RR. Lindquist RR. Immunopharmacol Immunotoxicol. 1992;14(1-2):129-39. doi: 10.3109/08923979209009216. Immunopharmacol Immunotoxicol. 1992. PMID: 1597652
51 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback